Producing Recombinant Glycoproteins in the Baculovirus-Insect Cell System - PowerPoint PPT Presentation

1 / 42
About This Presentation
Title:

Producing Recombinant Glycoproteins in the Baculovirus-Insect Cell System

Description:

Producing Recombinant Glycoproteins in the Baculovirus-Insect Cell System Donald L. Jarvis, Jason R. Hollister, Jared J. Aumiller Department of Molecular Biology – PowerPoint PPT presentation

Number of Views:145
Avg rating:3.0/5.0
Slides: 43
Provided by: wwwnmrCab
Category:

less

Transcript and Presenter's Notes

Title: Producing Recombinant Glycoproteins in the Baculovirus-Insect Cell System


1
Producing Recombinant Glycoproteins in the
Baculovirus-Insect Cell System
  • Donald L. Jarvis, Jason R. Hollister, Jared J.
    Aumiller
  • Department of Molecular Biology
  • University of Wyoming
  • Laramie, WY, USA

2
Baculovirus-Insect CellExpression System
  • Binary system.
  • Recombinant baculovirus vector.
  • Delivers gene of interest.
  • Insect cell host.
  • Produces protein product.

3
AdvantagesBaculovirus-Insect Cell System
  • High level gene expression.
  • Strong promoter from viral polh gene.
  • Eucaryotic protein processing.
  • Glycosylation.

Jarvis, 1997
4
Protein Glycosylation
  • Common covalent modification.
  • Can influence protein function.
  • Elaborate biochemical pathways.
  • N-glycosylation.

5
Mammalian N-glycosylationPathway
6
Mammalian N-glycans
7
Major Insect N-glycans
8
Major Insect vs Mammalian N-Glycans
Marchal et al., 2001
9
Glycoprotein Sialylation
  • Functionally significant.
  • Influences glycoprotein behavior.
  • Nonsialylated gP rapidly cleared in vivo.

10
Major DisadvantageBaculovirus-Insect Cell System
  • Truncated N-glycosylation pathway.
  • Cannot produce sialylated N-glycans.

Marchal et al., 2001
11
How to Address this Problem?
  • Metabolic engineering.
  • Genetically modify (humanize) insect protein
    N-glycosylation pathway.

12
Humanizing Insect Protein Glycosylation Pathways
  • Identify missing functions.
  • Identify human/mammalian genes.
  • Place under control of insect promoters.
  • Genetically transform insect cell lines.
  • Isolate transgenic insect cells that
    constitutively express these genes.

Jarvis et al., 1998 Jarvis et al., 2003, Jarvis,
2003
13
Major Insect vs Mammalian N-Glycans
14
Immediate Early Expression Plasmids
15
A Dual Immediate Early Expression Plasmid
16
Creating Transgenic Insect Cell Lines
  • Constructed pIE1ß4GalT, pIE1ST6, pIE1Neo.
  • Cotransfected Sf9 or High Five cells.
  • Isolated drug-resistant clones.
  • Screened for glycosyltransferase expression.

17
Transgenic Insect Cell Lines
  • Normal morphologies.
  • Normal growth properties.
  • Support baculovirus infection.
  • Support baculovirus gene expression.
  • Constitutive Gal-T and Sial-T activities.
  • Can they produce humanized glycoproteins?

Breitbach and Jarvis, 2001 Hollister et al.,
1998 Hollister and Jarvis 2001
18
gp64 Lectin Blots
No competing sugars
1-Sf9 2-Sfß4GalT 3-Sfß4GalT/ST6
Competing sugars
Hollister and Jarvis, 2001
19
HPAEC-PAD Results
M3F
Sf9
M3
Sfß4GalT
GalGlcNAcM3F
Sfß4GalT/ST6
SialylGalGlcNAcM3F
Hollister et al., 2002
20
MALDI-TOF Results
1079
Sf9



933
1445
Relative Abundance
Sfß4GalT
1079


1079
1445
Sfß4GalT/ST6
1758
1736
1283
1607
Hollister et al., 2002
21
Conclusions
  • Transgenic insect cell lines produced partially
    humanized N-glycans.
  • Galactosylated and sialylated.
  • But, they were monoantennary.
  • Only a3 branch was elongated.

22
Next Question
  • Can insect cells be further humanized to produce
    BIantennary, sialylated N-glycans?

23
Major Insect vs Mammalian N-Glycans
24
A New Transgenic Cell Line SfSWT-1
  • ß1,4-galactosyltransferase.
  • a2,6-sialyltransferase.
  • N-acetylglucosaminyltransferase II.
  • N-acetylglucosaminyltransferase I.
  • a2,3-sialyltransferase.

Hollister et al., 2002
25
SfSWT-1 Cells
  • Normal morphology and growth.
  • Support baculovirus infection.
  • Support baculovirus gene expression.
  • Express all five transferase genes.
  • Can they produce biantennary N-glycans?

Hollister et al., 2002
26
HPAEC-PAD Results
M3F
Sf9
M3
Sfß4GalT
GalGlcNAcM3F
Sfß4GalT/ST6
SialylGalGlcNAcM3F
SfSWT-1
GalGlcNAc2M3F
SialylGalGlcNAc2M3F
Hollister et al., 2002
27
MALDI-TOF Results
Sf9
Sfß4GalT
Sfß4GalT/ST6
SfSWT-1
Hollister et al., 2002
28
ESI-MS/MS Results
SfSWT-1
1810
2123
1648
1283
1664
1445
1607
Hollister et al., 2002
29
ESI-MS/MS Results
SfSWT-1
1810
2123
1648
1283
1664
1445
1607
Hollister et al., 2002
30
Conclusions 2
  • Sf9 cells were engineered to produce biantennary,
    monosialylated N-glycans.
  • Commercially available.
  • MIMIC (Invitrogen).

31
Requirements for gP sialylation
  • Sialyltransferase.
  • Acceptor substrate (terminally galactosylated).
  • Donor substrate (CMP-sialic acid).
  • CMP-sialic acid transporter.

32
New Questions
  • Where does the donor CMP-SA come from?
  • How is it transported into the Golgi?

33
Effects of FBS on Glycosylation by Transgenic
Insect Cell Lines
FCS
NO FCS
(Sfß4GalT/ST6)
Hollister et al., 2003
34
FBS Factor is a Sialoglycoprotein
Hollister et al., 2003
35
Conclusions 3
  • Sfß4GalT/ST6 and SfSWT-1 cells require FBS or
    serum sialoglycoproteins for de novo glycoprotein
    sialylation.
  • These cells can salvage sialic acids from
    extracellular serum sialoglycoproteins.

Hollister et al., 2003
36
Final Question
  • Can we create a transgenic insect cell line that
    produces humanized recombinant glycoproteins when
    cultured in SFM?

37
Newest Transgenic Cell Line SfSWT-3
  • ß1,4-galactosyltransferase.
  • a2,6-sialyltransferase.
  • N-acetylglucosaminyltransferase II.
  • N-acetylglucosaminyltransferase I.
  • a2,3-sialyltransferase.
  • Sialic acid synthase.
  • CMP-sialic acid synthetase

Aumiller et al., 2003
38
SfSWT-3 Cells
  • Normal morphology and growth.
  • Support baculovirus infection.
  • Support baculovirus gene expression.
  • Express all seven mammalian genes.
  • Can they produce biantennary, sialylated
    N-glycans in the absence of serum?

Aumiller et al., 2003
39
Lectin Blotting Results
Antibody
Sial-specific lectin
Lectin competing sugar
Aumiller et al., 2003
40
HPAEC-PAD Results
SfSWT-3 SFM
SfSWT-3 SFM/ManNAc
SfSWT-3 SFM/ManNAc Neuraminidase control
Aumiller et al., 2003
41
Overall Summary
  • Genetic engineering can be used to extend insect
    cell protein glycosylation pathways.
  • New baculovirus-insect cell systems can produce
    structurally authentic glycoproteins.
  • Products appear to be quite homogeneous.
  • Amenable to crystallization and structural
    analysis.

42
Acknowledgements
  • Jason Hollister
  • Eric Finn
  • Carla Weinkauf
  • Neung-Seon Seo
  • Jared Aumiller
  • Dale Howe
  • Kevin Breitbach
  • NIH GM49734
  • Harald Conradt
  • Eckard Grabenhorst
  • Manfred Nimtz
  • Joel Shaper
  • Jim Paulson
  • Harry Schachter
  • Pamela Stanley
  • Shuichi Tsuji
Write a Comment
User Comments (0)
About PowerShow.com